Device evaluation: the contaminated device was received at the third-party decontamination facility on (b)(6) 2017.The sample was decontaminated and then shipped out to the manufacturing facility in (b)(6) for further evaluation.The "cracked" condition could be confirmed by visual inspection.The "cracked" condition was noted on the apl cap.This part is molded and supplied to vyaire by (b)(4).Vyaire's manufacturing facility assembles the component to the sub-assembly by using a pneumatic press.The personnel assembly processes and inspection test methods have been reviewed and evaluated and are believed to not contribute to the observed defect.Vyaire has completed a thorough evaluation of the personnel assembly process, manufacturing process, and functional testing has been performed on the returned sample device.A device history record was also performed for the reported lot number, and no issues were found.Incoming inspection is being performed per procedure by receiving, looking for any cosmetic defects on the supplied components for parts used in this finished good.The assembly process was reviewed in detail, and the components are being assembled per procedure using a pneumatic press.Vyaire completed additional testing on the pneumatic press attempting to replicate the failure in production.The failure was not reproduced.According to the investigation the defect is not related to internal processes based on current findings.Vyaire has initiated a capa, along with the initiated scar that has been issued to the supplier.Additional studies and testing are underway at the supplier level in partnership with vyaire.At this time no root cause has been identified at this time.
|